Semis Rule, Insiders Split, Earnings Loom
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Semiconductors Lead the Bull Case
Options traders are piling into semiconductors. Micron tops bullish flow rankings, up 219% year-to-date. Sandisk carries the highest ORTEX stock score in the screener at 94.92, up 466% YTD. Analysts at Truist lifted their Cisco target to $140 from $125, citing institutional demand. Chip equipment giant Applied Materials reports earnings today — a key read on semiconductor spending ahead.
Bears Pick Their Spots
Not everyone is bullish. AppLovin sits deep in bearish options flow. Its RSI14 is 26.6 — oversold — and the stock is down 55% YTD. Short sellers are also fresh on CoreCivic, where SI jumped from 2.3% to 10.3% in one week. Clinical-stage biotech Replimune saw short interest leap 10.9 percentage points to 43.3% of free float.
Insider Split: Gates Buys, Executives Sell
Bill Gates filed an $81M purchase in Republic Services across two days — 377,866 shares total. That's a large, deliberate bet on waste management. Encompass Health CEO Mark Tarr moved the other way, filing a $21.5M sale. Johnson & Johnson CEO Joaquin Duato sold $10.8M in shares filed August 7.
Retail Earnings Week Ahead
Wednesday August 19 brings a major consumer test. Lowe's and Target both report — two bellwethers for discretionary spending. Home Depot drops results Tuesday. Analyst upgrades at Cardinal Health, with JP Morgan lifting its target to $260 from $215, add to a picture of cautious optimism heading into the week.
Stocks in this article
How this article was generated
- Generated
- 13 Aug 2026, 16:52
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowORTEX Alpha signalsORTEX Alpha signalsAnalyst consensus
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.